U.S. pharma huge copyright scrapped two experimental weight loss supplements previous yr—a once-day by day pill, lotiglipron, resulting from elevated liver enzymes plus a 2 times-each day tablet, danuglipron, resulting from powerful Unwanted effects—but CEO Albert Bourla has claimed the company is decided to “play and get” during the obesit